BMEYE's haemodynamic monitors:
This article was originally published in Clinica
Executive Summary
Dutch firm BMEYE has received 510(k) market clearance from the US FDA for its line of noninvasive haemodynamic monitors. The monitors, which fall under the Nexfin brand, provide continuous blood pressure and cardiac output readings. The devices consist of an easy-to-apply finger sensor, and an intuitive touchscreen display, said the Amsterdam company. The Nexfin line was CE marked and launched in Europe in August.